ISRG vs REGN: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

ISRG has stronger fundamentals based on our AI analysis.

ISRG
INTUITIVE SURGICAL INC
BUY
90%
Confidence
VS
REGN
REGENERON PHARMACEUTICALS, INC.
BUY
80%
Confidence

ISRG vs REGN Fundamental Comparison

Metric ISRG REGN
Revenue $10.1B $14.3B
Net Income $2.9B $4.5B
Net Margin 28.4% 31.4%
ROE 16.0% 14.4%
ROA 14.0% 11.1%
Current Ratio 4.87x 4.13x
Debt/Equity 0.00x 0.06x
EPS $7.87 $41.48

Green = Better metric | Red = Weaker metric

View Full ISRG Analysis →
View Full REGN Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

ISRG vs AAPL REGN vs MSFT ISRG vs GOOGL REGN vs AMZN

ISRG vs REGN: Frequently Asked Questions

Is ISRG or REGN a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), ISRG has stronger fundamentals. ISRG is rated BUY (90% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.

How does ISRG compare to REGN fundamentally?

INTUITIVE SURGICAL INC has ROE of 16.0% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 28.4% vs 31.4% respectively.

Which stock pays higher dividends, ISRG or REGN?

ISRG has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ISRG or REGN for long term?

For long-term investing, consider that ISRG has BUY rating with 90% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ISRG vs REGN?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISRG vs REGN, the AI consensus favors ISRG based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.